Jonas O. Email & Phone Number

California, United States

Ingelheim Am Rhein, Rhineland-Palatinate, De

Supporting automation and digitalization efforts in through technology innovation.

South San Francisco, California, Us

● Authored the Data Review Tracker (DRT) for the Phase 1b R/R transplant or CAR-T eligible DLBCL (GO43693 study).● Supported in the clinical presentation of the GO43693 study protocol during the Site Initiation Visit (SIV).● Proposed language harmonization for Cytokine Release Syndrome (CRS)management across the CD20xCD3 bispecific molecules clinical trial protocols in response to FDA recommendations.● Performed study drug dose modification data review in Spotfire and the Roche cloud–based clinical data management system for a global phase III study in Relapsed or Refractory (R/R) Diffuse Large B-Cell Lymphoma (DLBCL) STARGLO clinical trial data review to determine dose modifications and adverse events.● Streamlined end-to-end tracking and management of protocol clarification letters (PCLs) through the authorship of a decision tree and tracker for the Roche enterprise digitalization of protocol (DOP) initiative, to avoid protocol deviation. ● Spearheaded the curation of a representative list of study protocols with various study schemas from the Roche cloud-based content management platform for the digitalization of protocol study archetype Smart Designer Vendors’ Proof of Concept (POC).● Conducted a thorough review of patient eligibility data for the GO42273 NRAS-mutant advanced melanoma study with gRED-Onc (Genentech Research and Early Development – Oncology Department) clinical trial.Key accomplishment: Holistic clinical science training in early and late-stage clinical development through protocol amendments, site initiation visits presentations, medical data review, Good Clinical Practice (GCP), International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH), and active participation in departmental and enterprise-wide initiatives.

Thousand Oaks, Ca, Us

● Conducted New Molecular Entity (NME) analysis in oncology and ophthalmology biosimilar markets.● Performed Probability of Technical and Regulatory Success (PTRS) analysis for the oncology and ophthalmology biosimilar markets to assess the project feasibility.● Analyzed research data for Life Cycle Management (LCM) opportunities for the oncology and ophthalmology biosimilars to retain a competitive edge.● Conducted internal stakeholder informational interviews to better understand the Amgen Biosimilars vision and the impact of the oncology and ophthalmology biosimilars on the pipeline.● Presented recommendations to Amgen, on market entry timing and strategy, and potential strategic mergers and/or acquisitions for entry into the oncology and ophthalmology biosimilar markets.Key accomplishments: Development of a keen edge in competitive analysis to bolster drug market entry timing and strategy, as well as Life Cycle Management strategies, and sharpening of oral and written communication skills.

Rancho Cucamonga, Ca, Us

● Co-managed Kahook Dual Blade (KDB) GLIDE cross-functional development and launch team, and project activities.● Performed beta analysis as part of competitive intelligence of Glaucoma indication in the ophthalmology therapeutic area.● Performed a market forecast of New World Medical’s KDB and Ahmed Glaucoma valve that contributed directly to the following fiscal year’s marketing plan development for the US market.● Developed a business case for a portable Selective Laser Trabeculoplasty (SLT) device.Key accomplishments: Speedy adaptation to a new therapeutic area (ophthalmology) and methodologies of insights extraction from market reports and primary market research data. Strengthened project management skills through the management of medical device launch activities.

Switzerland 🇨🇭 , Ch

● Generated a competitive intelligence framework in the RNA Sequencing (RNA-Seq) market to understand the trends and inclinations of the RNASeq market landscape.● Performed primary market research with Key Opinion Leaders (KOLs) and stakeholders in the RNASeq market landscape to determine the existing technology gaps and market niche.● Presented recommendations to Roche, on technology gaps and emerging trends in the RNASeq market landscape based on data analysis.Key accomplishments: Development of primary market research skills, and data summary and presentation skills, gaining a holistic understanding of molecular diagnostics and companion diagnostics development.

Monrovia, California, Us

Graduate Student Consultant● Generated a competitive intelligence framework to classify competitors' in vitro diagnostic devices in the infectious disease landscape.● Collated, organized, and presented data from competitive intelligence analysis to inform Efyian's product development efforts.

Pasadena, California, Us

● Assessed the library preparation and sequencing market landscape for potential uses for Poseidon’s phage display library preparation technology● Investigated prospective use case scenarios and applications for Poseidon's platform technology.● Identified potential partnership prospects for Poseidon LLC.

Doctor Of Philosophy, Applied Life Sciences

Master'S Degree, Business And Science (Biotech Management)

Bachelor Of Science - Bs, Biochemistry, Cell And Molecular Biology